🧫
CD2AP downregulation in brain endothelial cells - memory function
active
experiment
Created: 2026-04-06T12:34:31
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-954cc8d7-2e29-4aa4-bd85-b7283b995faa
🧫 Experiment Protocol
ValidationAlzheimer's diseaseCD2APmiceproposed
Genetic downregulation of CD2AP specifically in brain vascular endothelial cells to assess the impact on memory function in mice. This experiment examined whether loss of endothelial CD2AP causes cognitive impairments, with particular focus on sex-dependent effects. Male mice showed impaired memory function when brain endothelial CD2AP was reduced.
PRIMARY OUTCOME
memory function impairment
EXPECTED OUTCOMES
1. The intervention targeting CD2AP shifts memory function impairment in the predicted direction relative to the matched control arm.
2. Secondary disease-relevant readouts in Alzheimer's disease remain directionally concordant with the primary endpoint rather than showing isolated single-assay effects.
3. The effect persists after adjustment for baseline covariates, batch effects, or repeated-measures structure used in the study design.
SUCCESS CRITERIA
- Prespecified primary endpoint (memory function impairment) improves versus control with p < 0.05 or an equivalent corrected threshold used by the study.
- The effect size is biologically meaningful and reproduced across technical/biological replicates or the validation subset.
- Safety, data quality, and missingness remain within protocol-defined bounds so the result is interpretable rather than driven by attrition or assay failure.
PROTOCOL
1. Establish mice cohorts for Alzheimer's disease and predefine inclusion, exclusion, and quality-control criteria before intervention. 2. Apply the experimental manipulation described for CD2AP, alongside matched control or comparator arms, and document dose, exposure window, and sample timing in a locked protocol log. 3. Measure memory function impairment together with orthogonal secondary readouts such as molecular, imaging, behavioral, or safety endpoints that are appropriate to the title and study design. 4. Use blinded outcome assessment where feasible, prespecified statistical analysis, and replicate the core readout across biological replicates or an independent validation subset. 5. Interpret results against the baseline study rationale: Genetic downregulation of CD2AP specifically in brain vascular endothelial cells to assess the impact on memory function in mice. This experiment examined whether loss of endothelial CD2AP causes cognitive impairments, with particular focus on sex-dependent ef
LINKED HYPOTHESES
Source: PMID 39892386 ↗
🧫 Experiment Extras
PATHWAY
cerebrovascular function
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.